Elevance Health Inc (ELV)

Net profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net income (ttm)	US$ in thousands	5,987,000	6,127,000	6,441,000	6,241,000	6,041,000	6,182,000	6,088,000	6,228,000	6,104,000	5,518,000	4,231,000	4,714,000	4,572,000	4,955,000	5,916,000	4,779,000	4,807,000	4,297,000	4,074,000	3,989,000
Revenue (ttm)	US$ in thousands	171,340,000	168,622,000	165,712,000	160,672,000	156,595,000	153,247,000	149,130,000	144,349,000	138,639,000	133,882,000	129,218,000	124,631,000	121,867,000	117,450,000	112,966,000	109,168,000	104,213,000	100,179,000	96,756,000	94,234,000
Net profit margin		3.49%	3.63%	3.89%	3.88%	3.86%	4.03%	4.08%	4.31%	4.40%	4.12%	3.27%	3.78%	3.75%	4.22%	5.24%	4.38%	4.61%	4.29%	4.21%	4.23%

December 31, 2023 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $5,987,000K ÷ $171,340,000K
= 3.49%

The net profit margin of Elevance Health Inc has shown some variability over the past eight quarters. In Q4 2023, the net profit margin was 3.52%, a slight decrease from the previous quarter. This decrease followed a relatively stable trend in the net profit margin, which ranged from 3.87% to 4.13% over the previous quarters. Despite some fluctuations, the net profit margin has generally remained within a narrow range, indicating a consistent level of profitability relative to the company's net sales during this period. Further analysis would be needed to understand the factors driving the changes in the net profit margin and to assess the company's overall financial performance.